Nissan Chemical Corporation FY2027 Q1 Earnings Report

Quick View

Executive Summary

Revenue and profit both achieved double-digit growth, resulting in higher revenue and earnings, with the high-margin Functional Materials and Agricultural Chemicals segments driving the improvement in profitability. Revenue was ¥787.9B (¥698.7B in the same period of the previous year, +12.8%), Operating Income was ¥219.1B (¥181.0B, +21.1%), Ordinary Income was ¥236.4B (¥181.4B, +30.3%), and Net Income attributable to owners of the parent was ¥168.4B (¥138.9B, +21.2%). The gross profit margin improved to 50.6% from the previous year, with pricing policies and an improved product mix serving as the primary drivers of earnings growth.

Factors Affecting Business Performance

【Revenue】Revenue was ¥787.9B (+12.8%). Wholesale Business increased substantially to ¥383.5B (+27.9%), while Functional Materials rose to ¥326.0B (+26.1%), driving overall company growth. Agricultural Chemicals was ¥266.0B and remained largely flat (+0.0%), indicating that growth was dependent on other segments. Healthcare was a small-scale business at ¥18.6B (+18.2%) but achieved high growth.

【Profit and Loss】Operating Income was ¥219.1B (+21.1%), and the Operating Margin improved to 27.8% from 25.9% in the previous year. The Cost of Sales ratio declined, improving the gross profit margin by +180bp to 50.6% from 48.8% in the previous year, while the SG&A ratio remained broadly flat at 22.7%, demonstrating continued cost discipline. Ordinary Income was ¥236.4B (+30.3%), supported by non-operating income including dividend income of ¥9.5B and foreign exchange gains of ¥4.3B. Functional Materials (32.8% margin) and Agricultural Chemicals (33.2%) maintained high profitability and supported overall earnings, whereas Wholesale Business had a thin 3.6% margin, meaning that despite having the largest share of revenue, its contribution to profit was limited. The results were characterized by higher revenue and earnings, as well as a structural improvement in profit margins.

Segment Analysis

The Functional Materials Business generated revenue of ¥326.0B (+26.1%), Operating Income of ¥106.9B (+30.3%), and a 32.8% margin, making it the company’s largest profit-contributing segment. The Agricultural Chemicals Business maintained high profitability with a 33.2% margin despite revenue of ¥266.0B (+0.0%), making its lack of volume growth a point to monitor going forward. The Wholesale Business had the largest revenue scale at ¥383.5B (+27.9%), but its margin was low at 3.6%; the gross presentation of agent transactions resulted in a significant difference between revenue scale and profit contribution. The Healthcare Business was small in scale but demonstrated the highest profitability, with a 39.8% margin, and also achieved the fastest growth (+50.2%).

Key Financial Indicators

【Profitability】Both the Operating Margin of 27.8% (25.9% in the previous year) and the Net Profit Margin of 21.4% (19.9% in the previous year) improved, primarily due to the improvement in the gross profit margin to 50.6% from 48.8%. 【Cash Flow Quality】Operating Cash Flow (OCF) was ¥212.2B, or 1.26 times Net Income of ¥168.4B, indicating a favorable level of earnings cash conversion. 【Investment Efficiency】ROE was 6.7%. Given the conservative capital structure, with an Equity Ratio of 70.9%, the leverage effect was limited. EPS expanded to ¥125.74 (¥102.20 in the previous year, +23.0%), exceeding the pace of earnings growth. 【Financial Soundness】The Equity Ratio was 70.9%, and the company held cash and deposits of ¥351.8B. Bonds outstanding had doubled year on year to ¥200.0B. Total assets were ¥3599.5B and net assets were ¥2551.7B, representing a balanced structure in terms of capital efficiency and financial soundness.

Cash Flow Analysis

Operating Cash Flow was ¥212.2B (+29.9% year on year), demonstrating strong cash generation that exceeded Net Income of ¥168.4B. In terms of working capital, inventories and trade receivables made negative contributions of ¥15.4B and ¥28.6B, respectively. Although the accumulation of inventories and receivables associated with higher revenue somewhat restrained OCF growth, the ¥11.1B increase in trade payables partially offset this effect. Investing Cash Flow was an outflow of ¥61.5B, primarily reflecting capital expenditures of ¥41.6B. CapEx exceeded depreciation and amortization of ¥36.0B, indicating the continuation of replacement and growth investments. Free Cash Flow was secured at ¥150.8B, but Financing Cash Flow was an outflow of ¥167.2B. In addition to share repurchases of ¥47.1B, the payment of the year-end dividend resulted in a modest decline in cash and deposits during the quarter. This concentration of funding needs was largely seasonal and does not represent a major concern in light of the company’s full-year OCF generation capacity.

Earnings Quality

Of Ordinary Income of ¥236.4B, non-operating income of ¥21.2B consisted primarily of dividend income of ¥9.5B and foreign exchange gains of ¥4.3B. Both were income derived from non-operating activities and had only a limited impact, equivalent to 2.7% of revenue. Equity-method income provided a positive contribution of ¥4.0B, and the performance of affiliated companies also supported Ordinary Income. Comprehensive Income was ¥180.0B, of which ¥176.8B was attributable to owners of the parent. The difference from Net Income of ¥168.4B was primarily attributable to an ¥8.7B increase in valuation difference on securities, representing a valuation fluctuation factor separate from the earning power of the core business. Although OCF exceeded Net Income, increases in trade receivables and inventories represented accrual factors. Given that these increases were natural asset growth associated with higher revenue, earnings quality can generally be assessed as favorable.

Earnings Forecast and Guidance

Against the full-year plan, revenue was ¥78.8B out of ¥287.0B, representing progress of 27.2%; Operating Income was ¥219.1B out of ¥668.0B, representing progress of 32.8%; and Ordinary Income was ¥236.4B out of ¥688.0B, representing progress of 34.4%. All exceeded the quarterly benchmark of 25%. In particular, progress on profit indicators exceeded that of revenue, raising the question of whether the factors boosting profitability in the first half will continue into the second half and beyond, or whether the full-year plans themselves were set conservatively. No revisions were made to the earnings forecast or dividend forecast as of the full-year financial results announcement.

Shareholder Returns

The full-year dividend forecast is ¥212, implying a Payout Ratio of approximately 54.8% against forecast EPS of ¥387.11, which is not excessive. During the quarter, the company conducted share repurchases of ¥47.1B, and including the year-end dividend payment, approximately ¥166.7B of funds flowed out through Financing Cash Flow. Dividends have been paid continuously, with the annual dividend plan expanding from ¥70 per share in the previous year to ¥212 this fiscal year. Total shareholder returns, including dividends and share repurchases, exceeded quarterly Free Cash Flow of ¥150.8B. This was attributable to the timing of the year-end dividend payment and its seasonal nature; considering the company’s full-year OCF generation capacity, there is no significant concern regarding sustainability.

Risk Factors

1. Declining working capital efficiency: Trade receivables and inventories increased by ¥28.6B and ¥15.4B, respectively, partially offsetting OCF growth. Although these increases were natural consequences of higher revenue, trends in inventory and collection cycles should be monitored going forward.

2. Imbalance in the earnings structure across segments: Wholesale Business accounted for 48.7% of the revenue mix (¥383.5B), but had a thin 3.6% margin. The gross presentation of agent transactions resulted in a significant difference between revenue scale and profit contribution.

3. Dependence on short-term funding structure: Short-term borrowings stood at ¥165.5B, compared with only ¥3.9B in long-term borrowings, resulting in a funding structure biased toward the short term. Cash and deposits of ¥351.8B provide a certain level of buffer.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The company’s profitability substantially exceeds the industry median and places it among the high-profitability group within the manufacturing industry.

Growth and Capital Efficiency

The growth rate also exceeds the industry median but remains within the IQR upper bound of 14.6%.

※Source: Compiled by the Company

Key Points from the Financial Results

1. Both the gross profit margin and Operating Margin improved from the previous year, and the expansion in the revenue mix of high-margin segments such as Functional Materials and Agricultural Chemicals may be contributing structurally to the improvement in the company-wide earnings profile.

2. Full-year progress is advancing at a faster pace for profit indicators than for revenue (Operating Income at 32.8% versus revenue at 27.2%), indicating a concentration of profitability in the first half. Changes in the pace of progress during the second half and thereafter will be a key point of focus.

3. Although Wholesale Business has the largest share of revenue, its margin is low at 3.6%, and its contribution to company-wide profit is limited. Differences in the earnings structure by segment warrant close monitoring as a potential factor affecting future changes in the company-wide profit margin.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson type; explicit 5-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.

Sensitivity: ¥2,569–¥2,717 at Cost of Equity ±1%, and ¥2,624–¥2,668 at ω±0.1.

Notes:

• Goodwill amortization of ¥0.5 per share is added back to earnings (as a non-cash expense and for comparability with IFRS companies).
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-07 / This value does not forecast or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL financial results data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available financial results data. Investment decisions should be made at your own responsibility, and after consulting with a professional advisor as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Nissan Chemical delivered a strong FY2027 Q1 result, with profit growth materially outpacing revenue growth and profitability remaining exceptionally high. Revenue rose 12.8% year on year to JPY78.79bn. Operating income increased 21.1% to JPY21.91bn, producing an operating margin of 27.8%, up 190bp from 25.9% in the prior-year quarter. Net income attributable to owners rose 21.2% to JPY16.84bn. The gross margin improved 180bp to 50.6%, demonstrating favorable product mix and/or pricing relative to production costs. SG&A increased 12.0% to JPY17.93bn, broadly in line with revenue growth and therefore did not dilute operating leverage. Ordinary income rose a faster 30.3% to JPY23.64bn, supported by JPY2.12bn of non-operating income, including JPY0.95bn of dividend income and JPY0.43bn of foreign-exchange gains. The difference between ordinary income and net income reflects a normal 27.5% effective tax rate rather than an identified extraordinary item. Operating cash flow of JPY21.22bn exceeded net income by 26%, supporting the cash-backed nature of reported earnings. Free cash flow was a robust JPY15.08bn after JPY4.16bn of capital expenditure. Cash conversion, at 0.83x of EBITDA, was solid but below the 0.9x excellent benchmark as working-capital investment absorbed part of EBITDA. The principal operational concern is working-capital intensity: reported receivable days of 116 days, inventory-day alerts of 134 and 183 days, and a 244-day cash conversion cycle indicate a long cash cycle for a manufacturing group. Liquidity is nevertheless very strong, with a 296.0% current ratio, JPY147.94bn of working capital, and cash equal to 2.13x short-term debt. The full-year forecast appears achievable based on Q1 progress, with revenue at 27.2% of target and operating income at 32.8%. The earnings outlook is underpinned by Functional Materials and Agricultural Chemicals, though the company must convert elevated receivables and inventories into cash while managing its predominantly short-term debt maturity profile.

Profitability Analysis

Annualized DuPont ROE is 26.4%, decomposed into a 21.4% net profit margin, 0.876x asset turnover, and 1.41x financial leverage. This is a high-quality return profile because it is driven primarily by an exceptional margin rather than aggressive leverage; financial leverage is modest and the balance sheet is equity-funded. The Q1 operating margin expanded 190bp year on year to 27.8%, while gross margin expanded 180bp to 50.6%, indicating that gross-profit improvement was retained through the operating line. Operating income growth of 21.1% exceeded revenue growth of 12.8% by 8.3 percentage points, evidencing favorable operating leverage. SG&A rose approximately 12.0% year on year, slightly below revenue growth, so overhead discipline contributed modestly to margin expansion. The extended DuPont tax burden was 0.712, consistent with the 27.5% effective tax rate and not indicative of an unusually adverse tax burden. The interest burden of 1.079 reflects net non-operating income exceeding interest expense, while interest expense of JPY0.13bn was immaterial relative to EBIT; EBIT interest coverage was 165.96x. EBITDA was JPY25.51bn and the EBITDA margin was 32.4%, reinforcing the strength of underlying operating profitability. Goodwill amortization was only JPY0.02bn, or less than 0.1% of EBITDA, so JGAAP goodwill amortization has no meaningful distortion of comparability or net income. Functional Materials was the core business by segment operating-income contribution, generating JPY10.69bn of segment profit, or 46% of aggregate segment profit before corporate adjustments, on JPY20.65bn of external revenue. Its segment profit increased 30.3% year on year, outpacing its 9.6% external-revenue growth, and its indicative segment margin was 51.7%. Agricultural Chemicals generated JPY23.63bn of external revenue and JPY8.84bn of segment profit, with profit up 2.2%, while Chemicals earned JPY0.87bn, Healthcare JPY0.74bn, Wholesale JPY1.40bn, and Other JPY0.54bn. Wholesale revenue grew 28.2% to JPY28.74bn, but its indicative segment margin was only 4.9%, underscoring that consolidated profit is principally dependent on the higher-margin Functional Materials and Agricultural Chemicals businesses. Corporate and consolidation adjustments improved to negative JPY1.18bn from negative JPY1.53bn, providing an additional JPY0.35bn benefit to consolidated operating income.

Growth Assessment

The growth profile was favorable in Q1: revenue grew 12.8%, operating income 21.1%, ordinary income 30.3%, and net income attributable to owners 21.2%. Growth was therefore accompanied by broad margin expansion rather than achieved through lower-margin volume alone. Functional Materials was the largest driver of incremental segment profit, adding JPY2.49bn year on year. Agricultural Chemicals maintained a large profit base, but its segment-profit growth of 2.2% lagged the group, making its future growth rate an important determinant of consolidated momentum. Chemicals and Healthcare delivered faster segment-profit growth of 22.8% and 50.2%, respectively, albeit from smaller earnings bases. Wholesale revenue growth was strong, but its lower profitability limits its contribution to group margin expansion. The company forecasts FY2027 revenue of JPY289.70bn, operating income of JPY66.80bn, ordinary income of JPY68.80bn, and net income attributable to owners of JPY51.50bn. Q1 progress against guidance is 27.2% for revenue, 32.8% for operating income, 34.4% for ordinary income, and 32.7% for net income. Each progress rate is above the standard 25% first-quarter run rate, but none exceeds it by more than 10 percentage points; the Q1 result is encouraging without mechanically implying a forecast revision. Management has maintained both earnings and dividend guidance. The two-period margin assessment is stable, while the reported consistency score of 2/10 indicates limited multi-period evidence for judging the durability of the current growth pattern. Revenue sustainability should therefore be assessed through continued Functional Materials demand, Agricultural Chemicals performance, customer collections, and inventory normalization rather than extrapolating a single quarter's margin expansion.

Financial Health

Financial health is strong on conventional liquidity and leverage measures. Current assets of JPY223.44bn exceeded current liabilities of JPY75.50bn by JPY147.94bn, resulting in a 296.0% current ratio and 220.4% quick ratio. These ratios are well above healthy benchmarks and provide substantial near-term liquidity coverage. Total equity was JPY255.17bn, equal to 70.9% of total assets, while total liabilities represented only 29.1% of assets. Reported debt-to-equity was 0.41x, debt-to-capital was 6.2%, and debt-to-EBITDA was 0.66x, all consistent with a conservative solvency position. Interest coverage of 165.96x and EBITDA interest coverage of 193.27x indicate no meaningful earnings-based debt-servicing strain. The material maturity issue is the 97.7% short-term debt ratio, which triggers the refinancing-risk alert because nearly all reported interest-bearing debt is short dated. This refinancing exposure is mitigated substantially by JPY35.18bn of cash and deposits, equivalent to 2.13x short-term debt, and by the large quick-asset surplus. Still, the investment case should distinguish ample liquidity from maturity concentration: the latter leaves funding costs and market-access conditions relevant at rollover dates. Bonds payable increased by JPY10.00bn year on year to JPY20.00bn, while short-term loans decreased by JPY3.13bn to JPY16.55bn and commercial paper declined by JPY1.00bn to JPY6.99bn, indicating an element of funding-term diversification. Treasury stock increased in absolute negative balance by JPY4.68bn to negative JPY8.10bn, reflecting the JPY4.71bn Q1 share repurchase and reducing equity modestly. This capital return is readily absorbable given the high equity ratio, but it increases the importance of maintaining cash conversion and disciplined debt maturity management.

Notable B/S Changes

Treasury stock: increased in absolute negative balance by JPY4.68bn to negative JPY8.10bn (-136.7%) - principally reflects JPY4.71bn of Q1 share repurchases, modestly reducing equity while enhancing per-share capital allocation. Bonds payable: +JPY10.00bn to JPY20.00bn (+100.0%) - additional bond funding supports liquidity and partially diversifies funding, though short-term debt remains the dominant reported maturity profile. Construction in progress: +JPY1.81bn to JPY7.77bn (+30.3%) - indicates an expanding investment pipeline that should be monitored for commissioning timing and returns on incremental capital. Commercial paper: -JPY1.00bn to JPY6.99bn (-12.5%) and short-term loans: -JPY3.13bn to JPY16.55bn (-15.9%) - indicates a reduction in certain short-term funding lines, partly offset by higher bonds payable.

Cash Flow Quality

Cash-flow quality was favorable in Q1. Operating cash flow was JPY21.22bn, 1.26x net income attributable to owners of JPY16.84bn, comfortably above the 1.0x high-quality benchmark and well above the 0.8x warning threshold. The accruals ratio was negative 1.2%, which is consistent with conservative cash realization rather than income being supported by aggressive accruals. EBITDA of JPY25.51bn converted into operating cash flow at 0.83x; this is sound, although below the 0.9x excellent benchmark. Free cash flow was JPY15.08bn after JPY4.16bn of capital expenditure, demonstrating internally funded investment capacity. CapEx was 1.15x depreciation and amortization, indicating a modest expansionary or asset-renewal investment stance rather than underinvestment. Operating cash flow included working-capital headwinds from a JPY2.86bn increase in trade receivables and a JPY1.54bn inventory increase, partly offset by a JPY1.11bn increase in trade payables. The high-receivable-days alert is material: annualized DSO of 116 days exceeds both the 60-day warning level and a typical manufacturing efficiency benchmark. The high-inventory-days alerts of 134 days and 183 days are both above relevant warning thresholds; although the reported measures use different inventory definitions, both point to slow inventory monetization. The 244-day annualized cash conversion cycle is correspondingly elevated and is the central working-capital risk. For a chemical manufacturer, this can reflect production lead times, customer credit terms, and inventory held to support supply continuity, but the magnitude warrants monitoring for demand normalization, product aging, or collection delays. There is no evidence in Q1 that weak operating cash flow is masking earnings, but continued growth in receivables or finished goods would weaken future free-cash-flow conversion.

Dividend Sustainability

The FY2027 full-year dividend forecast is JPY212 per share. Against forecast EPS of JPY387.11, the forecast dividend payout ratio is 54.8%, which is below the 60% sustainability benchmark and appears supportable by forecast earnings. Forecast net income attributable to owners of JPY51.50bn also provides a substantial earnings base for dividends. Q1 operating cash flow of JPY21.22bn and free cash flow of JPY15.08bn demonstrate strong underlying cash-generating capacity. However, cash dividends paid in Q1 were JPY17.72bn, exceeding Q1 free cash flow, and share repurchases of JPY4.71bn lifted Q1 cash distributions to JPY22.43bn. Accordingly, the Q1 total return cash outflow exceeded quarterly free cash flow by JPY7.36bn. This does not by itself indicate an unsustainable policy because dividend-payment timing may not align with quarterly earnings generation and the company holds substantial liquidity. Nevertheless, cash distributions should be monitored against full-year free cash flow rather than earnings alone, particularly given the long cash conversion cycle. The buyback means that distributions beyond dividends should be assessed as a total return ratio, not as a payout ratio. With no full-year buyback commitment provided, a full-year total return ratio cannot be calculated. Overall, the dividend outlook is supported by profitability, low leverage, and the stated absence of a dividend forecast revision, while the pace of buybacks and working-capital cash absorption remain key determinants of cash coverage.

Risk Assessment

Business risks include Functional Materials is the principal profit engine, contributing JPY10.69bn of segment profit; a slowdown in its end markets, product-cycle pressure, or price competition would have an outsized effect on group earnings., Agricultural Chemicals contributed JPY8.84bn of segment profit but grew only 2.2% year on year, leaving consolidated earnings sensitive to agricultural demand conditions, product registrations, weather-related purchasing patterns, and regulatory changes., Chemical manufacturing remains exposed to raw-material, energy, environmental-compliance, process-safety, and product-quality risks that can affect margins and operating continuity., Foreign-exchange gains of JPY0.43bn supported non-operating income in Q1; currency movements can add volatility to ordinary income even though the Q1 impact was small relative to operating profit., Wholesale revenue grew 28.2% but carries an indicative 4.9% segment margin, so a higher wholesale mix could constrain consolidated margin even if reported revenue continues to expand..

Financial risks include The 97.7% short-term debt ratio is a refinancing-risk alert. Cash coverage is strong at 2.13x short-term debt, but the high proportion of short-dated funding requires active rollover management., Annualized DSO of 116 days is a high-receivable-days alert and raises exposure to slower customer collection, customer credit deterioration, and incremental working-capital funding needs., Inventory-day alerts of 134 days and 183 days both exceed warning thresholds. Elevated inventory can create cash absorption, obsolescence, valuation, and future margin risks if demand weakens., The 244-day annualized cash conversion cycle is a long-CCC alert and indicates that accounting profits require a lengthy period to become distributable cash., Capital returns were substantial in Q1, with JPY17.72bn of dividends paid and JPY4.71bn of buybacks, exceeding quarterly free cash flow; sustained excess distributions would reduce financial flexibility..

Key concerns include Priority high: Normalize receivables, inventories, and the 244-day cash conversion cycle while preserving the current high operating margin., Priority medium: Manage the predominantly short-term debt structure despite strong liquidity, particularly if interest rates or funding-market conditions deteriorate., Priority medium: Sustain Functional Materials' 51.7% indicative segment margin and convert fast Wholesale revenue growth into value without diluting the group margin., Priority medium: Monitor whether Q1 operating-income progress of 32.8% versus full-year guidance is maintained through seasonal demand and segment mix changes..

Investment Implications

Key takeaways include Q1 was strong: revenue increased 12.8%, operating income increased 21.1%, and operating margin expanded 190bp to 27.8%., Annualized ROE of 26.4% is driven by a 21.4% net margin and low financial leverage, indicating strong operating economics rather than balance-sheet risk-taking., Functional Materials is the core earnings contributor, while Agricultural Chemicals remains a major profit pillar and Wholesale is a lower-margin revenue contributor., Operating cash flow exceeded net income and free cash flow was positive, supporting reported earnings quality., Working-capital efficiency, not balance-sheet liquidity, is the main financial issue: DSO, inventory days, and the cash conversion cycle are all elevated., Full-year guidance appears well supported by first-quarter progress, and the forecast dividend payout ratio of 54.8% is within a sustainable earnings-based range..

Metrics to watch include Functional Materials revenue growth and segment profit margin, Agricultural Chemicals profit growth and demand trajectory, Operating margin relative to the Q1 level of 27.8%, Annualized DSO of 116 days and movements in trade receivables, Inventory days, finished-goods balance, and the 244-day cash conversion cycle, Operating cash flow and free cash flow relative to net income and cash distributions, Short-term debt ratio, cash-to-short-term-debt coverage, and refinancing terms, Progress toward FY2027 guidance: revenue JPY289.70bn, operating income JPY66.80bn, and net income attributable to owners JPY51.50bn.

Regarding relative positioning, The company exhibits an unusually attractive combination for a Japanese chemical manufacturer of a 27.8% operating margin, 26.4% annualized ROE, 70.9% equity ratio, and net-income-backed operating cash flow. Relative strength is concentrated in high-margin Functional Materials, while the principal offset is materially less efficient working-capital conversion than standard manufacturing benchmarks and a funding structure concentrated in short-term maturities.